About this trial
Concussion (CC) (also called mild head trauma), which accounts for 85% of all head injuries, is very common in professional and amateur athletes. CC is an injury to the brain resulting from the direct or indirect impact of external mechanical forces, momentarily disrupting its function on a cellular level. Unlike more serious head injury (moderate and severe), which can be diagnosed using neuroimaging techniques (CT, MRI, etc.), patients suffering from CC do not necessarily show visible signs of structural abnormalities. As a result, diagnosis of CC is offen difficult.
Recently, several salivary biomarkers (proteins and nucleic acids) of sport related concussion have been identified in professional athletes. However, their reference values have not been determined with sufficient robustness to enable their employment in concussion diagnostic tests.
Eligibility criteria
Qualifiers
Male participants aged between 18 and 50 years old.
Participants willing to comply with the study procedures.
Participants capable of understanding the purpose, nature, and methodology of the study.
Participants affiliated to a French social security system or beneficiaries of such a system.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Bio-fluid analysis for the implementation of a diagnostic test for sport related concussion
Treatment groups
Sponsors and collaborators
Sys2Diag
Lead sponsor
Centre National de la Recherche Scientifique, France
Collaborator